The amount youll pay each month, known as your co-pay, varies depending on your insurance plan
If approved, nerandomilast will provide another treatment option for patients with IPF, a condition with high unmet need
You might be on the fence right now or want something a little less aggressive toward weight loss
One of the most consequential changes in 2026 is the loss of exclusivity for semaglutide, beginning in early 2026 across major markets including India, China, Brazil, Turkey and Canada, with semaglutide having lost exclusivity in India on 20th March 2026
Hybrids 5 and 9 showed efficacy but no improvement, indicated by a similar blood glucose curve to peptide 1 (Fig